Interleukin-1 beta (IL-1β) is a pro-inflammatory cytokine involved in immune responses, fever, and inflammation. Measuring IL-1β helps assess inflammatory conditions.
Interleukin 1ß is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Interleukin 1ß is especially relevant when fatigue overlaps with brain fog, concentration problems, paresthesias, or other neurologically flavored symptoms. Even then, one value alone rarely resolves the whole picture.
Interleukin 1ß does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Interleukin-1 beta (IL-1β) is a signaling protein (cytokine) produced primarily by activated immune cells such as macrophages. It plays a central role in the body’s inflammatory response, helping to trigger fever, stimulate the production of other inflammatory mediators, and activate lymphocytes. Because IL-1β is a key driver of inflammation, blood levels are sometimes measured in the evaluation of chronic inflammatory disorders, autoinflammatory syndromes, and certain infections. However, IL-1β testing is less common in routine clinical practice and is often reserved for specialist settings or research.
Values below the reference range (lab-dependent, typically <5 pg/mL or <5 ng/L) are generally considered normal, as IL-1β is usually present at very low concentrations in healthy individuals. A low or undetectable level does not typically indicate a deficiency but may be expected. In some contexts, an inappropriately low IL-1β in the presence of active inflammation could suggest an unusual pattern, but isolated low values are not usually clinically significant.
Elevated IL-1β levels (above the lab-dependent reference range, e.g., >5 pg/mL or >5 ng/L) may indicate an active inflammatory process. High IL-1β can be seen in a variety of conditions, including infections (such as sepsis), autoimmune diseases (like rheumatoid arthritis), and autoinflammatory syndromes (e.g., CAPS – cryopyrin-associated periodic syndromes).
Markedly elevated levels may also be observed in rare genetic disorders involving IL-1β overproduction. Interpretation should consider the overall clinical picture, as IL-1β can be transiently elevated due to stress or acute illness.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Interleukin 1ß is especially relevant when fatigue overlaps with brain fog, concentration problems, paresthesias, or other neurologically flavored symptoms. Even then, one value alone rarely resolves the whole picture.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Interleukin-1 Beta (IL-1β) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal range is lab-dependent, often considered to be below 5 pg/mL (or 5 ng/L) in healthy individuals. Because IL-1β circulates at very low levels, some healthy people may have undetectable values. Always compare with the specific lab's reference range.
A high IL-1β level suggests active inflammation. It may be associated with infections, autoimmune diseases like rheumatoid arthritis, or autoinflammatory conditions such as CAPS. However, levels can also rise temporarily due to stress or acute illness, so results must be interpreted by a healthcare provider.
IL-1β is naturally very low or undetectable in healthy people, so a low result is not usually a concern. There is no recognized medical condition caused by IL-1β deficiency, and a low value simply reflects the absence of significant inflammation.
Interleukin 1ß does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Interleukin 1ß is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
https://www.printo.it/pediatric-rheumatology/DE/info/19/Defizienz-des-Interleukin-1-Rezeptor-Antagonisten-(DIRA)
printo.it
https://www.gesundheit.gv.at/labor/laborwerte/infektionen-bakterien/interleukin-6.html
gesundheit.gv.at
https://flexikon.doccheck.com/de/Interleukin
flexikon.doccheck.com
https://www.imd-berlin.de/spezielle-kompetenzen/immundefekte/diagnostikstrategien/nk-zell-funktionstest
imd-berlin.de
https://naturheilzentrum-breidenbach.de/th1-th2-immunbalance/
naturheilzentrum-breidenbach.de
https://dgrh.de/dam/jcr:29498ad0-470e-459f-b60a-69a65e114315/anakinra_il_1beta_blocker_2009.pdf
dgrh.de
https://www.medmedia.at/faktenrheumatologie/blockierung-von-interleukin-1/
medmedia.at
https://de.wikipedia.org/wiki/Interleukin-1%CE%B2
de.wikipedia.org
https://refubium.fu-berlin.de/bitstream/fub188/32850/1/Diss_F.Wohlgemuth.pdf
refubium.fu-berlin.de
https://flexikon.doccheck.com/de/Procalcitonin
flexikon.doccheck.com
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
